{"transactions":[{"id":1511586,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-17T23:10:13.000Z","date":"2024-05-16","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"A total of 493,381 shares subject to an employee stock option were granted on April 2, 2021, with 25% vested on June 4, 2022, with the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":343381,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001415889-24-013629","document":"form4-05172024_070501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924013629/form4-05172024_070501.xml","form_type":"4"}},{"id":1511585,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-05-17T23:10:13.000Z","date":"2024-05-16","kind":"sale","planned":true,"acquired":false,"shares":1293,"price":21.922,"value":28345.146,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $21.87 to $22.035, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-24-013629","document":"form4-05172024_070501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924013629/form4-05172024_070501.xml","form_type":"4"}},{"id":1511584,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-05-17T23:10:13.000Z","date":"2024-05-16","kind":"sale","planned":true,"acquired":false,"shares":8707,"price":21.5241,"value":187410.3387,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.87 to $21.84, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1293,"source":{"system":"sec-edgar","filing":"0001415889-24-013629","document":"form4-05172024_070501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924013629/form4-05172024_070501.xml","form_type":"4"}},{"id":1511583,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-05-17T23:10:13.000Z","date":"2024-05-16","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":2.14,"value":21400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001415889-24-013629","document":"form4-05172024_070501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924013629/form4-05172024_070501.xml","form_type":"4"}},{"id":1528441,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-03T22:00:11.000Z","date":"2024-05-01","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"A total of 493,381 shares subject to an employee stock option were granted on April 2, 2021, with 25% vested on June 4, 2022, with the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":353381,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001415889-24-012234","document":"form4-05032024_060501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924012234/form4-05032024_060501.xml","form_type":"4"}},{"id":1528440,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-05-03T22:00:11.000Z","date":"2024-05-01","kind":"sale","planned":true,"acquired":false,"shares":1357,"price":19.91,"value":27017.87,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023."},{"field":"shares","element":"transactionShares","label":"F4","text":"Includes 1,357 shares purchased under the Issuer's 2021 Employee Stock Purchase Plan on April 30, 2024 in a transaction that is exempt under Rule 16b-3(c) and 16b-3(d)."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-24-012234","document":"form4-05032024_060501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924012234/form4-05032024_060501.xml","form_type":"4"}},{"id":1528439,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-05-03T22:00:11.000Z","date":"2024-05-01","kind":"sale","planned":true,"acquired":false,"shares":965,"price":20.8653,"value":20135.0145,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.855 to $20.89, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-24-012234","document":"form4-05032024_060501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924012234/form4-05032024_060501.xml","form_type":"4"}},{"id":1528438,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-05-03T22:00:11.000Z","date":"2024-05-01","kind":"sale","planned":true,"acquired":false,"shares":9035,"price":20.3423,"value":183792.6805,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.855 to $20.85, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":965,"source":{"system":"sec-edgar","filing":"0001415889-24-012234","document":"form4-05032024_060501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924012234/form4-05032024_060501.xml","form_type":"4"}},{"id":1528437,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-05-03T22:00:11.000Z","date":"2024-05-01","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":2.14,"value":21400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001415889-24-012234","document":"form4-05032024_060501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924012234/form4-05032024_060501.xml","form_type":"4"}},{"id":1539239,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-18T22:00:07.000Z","date":"2024-04-16","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"A total of 493,381 shares subject to an employee stock option were granted on April 2, 2021, with 25% vested on June 4, 2022, with the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":363381,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001415889-24-011144","document":"form4-04182024_060401.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924011144/form4-04182024_060401.xml","form_type":"4"}},{"id":1539238,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-04-18T22:00:07.000Z","date":"2024-04-16","kind":"sale","planned":true,"acquired":false,"shares":5509,"price":24.9428,"value":137409.8852,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.81 to $25.10, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-24-011144","document":"form4-04182024_060401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924011144/form4-04182024_060401.xml","form_type":"4"}},{"id":1539237,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-04-18T22:00:07.000Z","date":"2024-04-16","kind":"sale","planned":true,"acquired":false,"shares":4491,"price":24.3956,"value":109560.6396,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.80 to $24.785, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":5509,"source":{"system":"sec-edgar","filing":"0001415889-24-011144","document":"form4-04182024_060401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924011144/form4-04182024_060401.xml","form_type":"4"}},{"id":1539236,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-04-18T22:00:07.000Z","date":"2024-04-16","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":2.14,"value":21400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001415889-24-011144","document":"form4-04182024_060401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924011144/form4-04182024_060401.xml","form_type":"4"}},{"id":1549904,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-03T22:00:20.000Z","date":"2024-04-01","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"A total of 493,381 shares subject to an employee stock option were granted on April 2, 2021, with 25% vested on June 4, 2022, with the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":373381,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001415889-24-010138","document":"form4-04032024_060408.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924010138/form4-04032024_060408.xml","form_type":"4"}},{"id":1549903,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-04-03T22:00:20.000Z","date":"2024-04-01","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":31.95,"value":31950.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-24-010138","document":"form4-04032024_060408.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924010138/form4-04032024_060408.xml","form_type":"4"}},{"id":1549902,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-04-03T22:00:20.000Z","date":"2024-04-01","kind":"sale","planned":true,"acquired":false,"shares":2851,"price":31.0228,"value":88446.0028,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.73 to $31.46, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001415889-24-010138","document":"form4-04032024_060408.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924010138/form4-04032024_060408.xml","form_type":"4"}},{"id":1549901,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-04-03T22:00:20.000Z","date":"2024-04-01","kind":"sale","planned":true,"acquired":false,"shares":1647,"price":29.8955,"value":49237.8885,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.705 to $30.45, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":3851,"source":{"system":"sec-edgar","filing":"0001415889-24-010138","document":"form4-04032024_060408.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924010138/form4-04032024_060408.xml","form_type":"4"}},{"id":1549900,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-04-03T22:00:20.000Z","date":"2024-04-01","kind":"sale","planned":true,"acquired":false,"shares":4502,"price":28.9647,"value":130399.0794,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.57 to $29.48, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":5498,"source":{"system":"sec-edgar","filing":"0001415889-24-010138","document":"form4-04032024_060408.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924010138/form4-04032024_060408.xml","form_type":"4"}},{"id":1549899,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-04-03T22:00:20.000Z","date":"2024-04-01","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":2.14,"value":21400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001415889-24-010138","document":"form4-04032024_060408.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924010138/form4-04032024_060408.xml","form_type":"4"}},{"id":1665286,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-31T23:00:06.000Z","date":"2024-01-29","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest and become exercisable in 48 substantially equal monthly installments, with the first installment vesting on February 29, 2024."}],"balance_after":200000,"derivative":{"exercise_price":18.095,"expiration_date":"2034-01-28","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001415889-24-002089","document":"form4-01312024_060101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924002089/form4-01312024_060101.xml","form_type":"4"}},{"id":1749909,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2023-11-03T21:00:18.000Z","date":"2023-11-01","kind":"sale","planned":true,"acquired":false,"shares":1092,"price":10.42,"value":11378.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 18, 2022."},{"field":"shares","element":"transactionShares","label":"F2","text":"Includes 1,092 shares purchased under the Issuer's 2021 Employee Stock Purchase Plan on October 31, 2023 in a transaction that is exempt under Rule 16b-3(c) and 16b-3(d)."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-23-014773","document":"form4-11032023_051101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588923014773/form4-11032023_051101.xml","form_type":"4"}},{"id":1819311,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-01T22:00:14.000Z","date":"2023-07-28","kind":"exercise","planned":true,"acquired":false,"shares":5478,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"A total of 493,381 shares subject to an employee stock option were granted on April 2, 2021, with 25% vested on June 4, 2022, with the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":383381,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":5478},"source":{"system":"sec-edgar","filing":"0001415889-23-011677","document":"form4-08012023_060801.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588923011677/form4-08012023_060801.xml","form_type":"4"}},{"id":1819310,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2023-08-01T22:00:14.000Z","date":"2023-07-28","kind":"sale","planned":true,"acquired":false,"shares":5478,"price":18,"value":98604.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2022."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-23-011677","document":"form4-08012023_060801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588923011677/form4-08012023_060801.xml","form_type":"4"}},{"id":1819309,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2023-08-01T22:00:14.000Z","date":"2023-07-28","kind":"exercise","planned":true,"acquired":true,"shares":5478,"price":2.14,"value":11722.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2022."}],"balance_after":5478,"source":{"system":"sec-edgar","filing":"0001415889-23-011677","document":"form4-08012023_060801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588923011677/form4-08012023_060801.xml","form_type":"4"}},{"id":1826935,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-19T22:00:32.000Z","date":"2023-07-17","kind":"exercise","planned":true,"acquired":false,"shares":4522,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 24, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"A total of 493,381 shares subject to an employee stock option were granted on April 2, 2021, with 25% vested on June 4, 2022, with the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":388859,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":4522},"source":{"system":"sec-edgar","filing":"0001415889-23-011348","document":"form4-07192023_060719.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588923011348/form4-07192023_060719.xml","form_type":"4"}},{"id":1826934,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2023-07-19T22:00:32.000Z","date":"2023-07-17","kind":"sale","planned":true,"acquired":false,"shares":4522,"price":18.1106,"value":81896.1332,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 24, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.00 to $18.525, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-23-011348","document":"form4-07192023_060719.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588923011348/form4-07192023_060719.xml","form_type":"4"}},{"id":1826933,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2023-07-19T22:00:32.000Z","date":"2023-07-17","kind":"exercise","planned":true,"acquired":true,"shares":4522,"price":2.14,"value":9677.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 24, 2023."}],"balance_after":4522,"source":{"system":"sec-edgar","filing":"0001415889-23-011348","document":"form4-07192023_060719.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588923011348/form4-07192023_060719.xml","form_type":"4"}},{"id":1836508,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-05T22:00:05.000Z","date":"2023-07-03","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"A total of 493,381 shares subject to an employee stock option were granted on April 2, 2021, with 25% vested on June 4, 2022, with the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":393381,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001415889-23-010832","document":"form4-07052023_060701.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588923010832/form4-07052023_060701.xml","form_type":"4"}},{"id":1836507,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2023-07-05T22:00:05.000Z","date":"2023-07-03","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":18,"value":180000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2022."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-23-010832","document":"form4-07052023_060701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588923010832/form4-07052023_060701.xml","form_type":"4"}},{"id":1836506,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2023-07-05T22:00:05.000Z","date":"2023-07-03","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":2.14,"value":21400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2022."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001415889-23-010832","document":"form4-07052023_060701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588923010832/form4-07052023_060701.xml","form_type":"4"}},{"id":1906246,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-03T22:00:09.000Z","date":"2023-05-01","kind":"exercise","planned":true,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 18, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"A total of 493,381 shares subject to an employee stock option were granted on April 2, 2021, with 25% vested on June 4, 2022, with the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":403381,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001415889-23-007247","document":"form4-05032023_060501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588923007247/form4-05032023_060501.xml","form_type":"4"}},{"id":1906245,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2023-05-03T22:00:09.000Z","date":"2023-05-02","kind":"sale","planned":true,"acquired":false,"shares":693,"price":21.15,"value":14656.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 18, 2022."},{"field":"shares","element":"transactionShares","label":"F2","text":"Includes 693 shares purchased under the Issuer's 2021 Employee Stock Purchase Plan on April 30, 2023 in a transaction that is exempt under Rule 16b-3(c) and 16b-3(d)."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-23-007247","document":"form4-05032023_060501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588923007247/form4-05032023_060501.xml","form_type":"4"}},{"id":1906244,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2023-05-03T22:00:09.000Z","date":"2023-05-01","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":20.6059,"value":309088.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 18, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.05 to $21.01, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 693 shares purchased under the Issuer's 2021 Employee Stock Purchase Plan on April 30, 2023 in a transaction that is exempt under Rule 16b-3(c) and 16b-3(d)."}],"balance_after":693,"source":{"system":"sec-edgar","filing":"0001415889-23-007247","document":"form4-05032023_060501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588923007247/form4-05032023_060501.xml","form_type":"4"}},{"id":1906243,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2023-05-03T22:00:09.000Z","date":"2023-05-01","kind":"exercise","planned":true,"acquired":true,"shares":15000,"price":2.14,"value":32100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 18, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 693 shares purchased under the Issuer's 2021 Employee Stock Purchase Plan on April 30, 2023 in a transaction that is exempt under Rule 16b-3(c) and 16b-3(d)."}],"balance_after":15693,"source":{"system":"sec-edgar","filing":"0001415889-23-007247","document":"form4-05032023_060501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588923007247/form4-05032023_060501.xml","form_type":"4"}},{"id":1925256,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-05T22:00:09.000Z","date":"2023-04-03","kind":"exercise","planned":false,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"A total of 493,381 shares subject to an employee stock option were granted on April 2, 2021, with 25% vested on June 4, 2022, with the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":418381,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001415889-23-006321","document":"form4-04052023_060401.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588923006321/form4-04052023_060401.xml","form_type":"4"}},{"id":1925255,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2023-04-05T22:00:09.000Z","date":"2023-04-03","kind":"sale","planned":false,"acquired":false,"shares":5828,"price":19.7712,"value":115226.5536,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.51 to $20.22, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-23-006321","document":"form4-04052023_060401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588923006321/form4-04052023_060401.xml","form_type":"4"}},{"id":1925254,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2023-04-05T22:00:09.000Z","date":"2023-04-03","kind":"sale","planned":false,"acquired":false,"shares":9172,"price":19.155,"value":175689.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.50 to $19.50, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":5828,"source":{"system":"sec-edgar","filing":"0001415889-23-006321","document":"form4-04052023_060401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588923006321/form4-04052023_060401.xml","form_type":"4"}},{"id":1925253,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2023-04-05T22:00:09.000Z","date":"2023-04-03","kind":"exercise","planned":false,"acquired":true,"shares":15000,"price":2.14,"value":32100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2022."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001415889-23-006321","document":"form4-04052023_060401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588923006321/form4-04052023_060401.xml","form_type":"4"}},{"id":1963416,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-08T23:00:22.000Z","date":"2023-03-07","kind":"grant","acquired":true,"shares":139067,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest and become exercisable in 48 substantially equal monthly installments, with the first installment vesting on April 7, 2023."}],"balance_after":139067,"derivative":{"exercise_price":23.03,"expiration_date":"2033-03-06","underlying":"Common Stock","underlying_shares":139067},"source":{"system":"sec-edgar","filing":"0001415889-23-004514","document":"form4-03082023_060310.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588923004514/form4-03082023_060310.xml","form_type":"4"}},{"id":1974131,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-03T23:00:20.000Z","date":"2023-03-01","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"A total of 493,381 shares subject to an employee stock option were granted on April 2, 2021, with 25% vested on June 4, 2022, with the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":433381,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001415889-23-004192","document":"form4-03032023_060301.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588923004192/form4-03032023_060301.xml","form_type":"4"}},{"id":1974130,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2023-03-03T23:00:20.000Z","date":"2023-03-01","kind":"sale","acquired":false,"shares":1050,"price":25.67,"value":26953.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2022."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-23-004192","document":"form4-03032023_060301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588923004192/form4-03032023_060301.xml","form_type":"4"}},{"id":1974129,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2023-03-03T23:00:20.000Z","date":"2023-03-01","kind":"sale","acquired":false,"shares":5316,"price":24.6878,"value":131240.3448,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.33 to $25.06, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1050,"source":{"system":"sec-edgar","filing":"0001415889-23-004192","document":"form4-03032023_060301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588923004192/form4-03032023_060301.xml","form_type":"4"}},{"id":1974128,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2023-03-03T23:00:20.000Z","date":"2023-03-01","kind":"sale","acquired":false,"shares":2672,"price":23.8109,"value":63622.7248,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.31 to $24.20, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":6366,"source":{"system":"sec-edgar","filing":"0001415889-23-004192","document":"form4-03032023_060301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588923004192/form4-03032023_060301.xml","form_type":"4"}},{"id":1974127,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2023-03-03T23:00:20.000Z","date":"2023-03-01","kind":"sale","acquired":false,"shares":5962,"price":22.7071,"value":135379.7302,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.25 to $23.24, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":9038,"source":{"system":"sec-edgar","filing":"0001415889-23-004192","document":"form4-03032023_060301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588923004192/form4-03032023_060301.xml","form_type":"4"}},{"id":1974126,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2023-03-03T23:00:20.000Z","date":"2023-03-01","kind":"exercise","acquired":true,"shares":15000,"price":2.14,"value":32100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2022."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001415889-23-004192","document":"form4-03032023_060301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588923004192/form4-03032023_060301.xml","form_type":"4"}},{"id":2033190,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-03T23:00:21.000Z","date":"2023-02-01","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"A total of 493,381 shares subject to an employee stock option were granted on April 2, 2021, with 25% vested on June 4, 2022, with the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":448381,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001415889-23-001966","document":"form4-02032023_060202.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588923001966/form4-02032023_060202.xml","form_type":"4"}},{"id":2033189,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2023-02-03T23:00:21.000Z","date":"2023-02-01","kind":"sale","acquired":false,"shares":4495,"price":23.0502,"value":103610.649,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.815 to $23.435, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-23-001966","document":"form4-02032023_060202.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588923001966/form4-02032023_060202.xml","form_type":"4"}},{"id":2033188,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2023-02-03T23:00:21.000Z","date":"2023-02-01","kind":"sale","acquired":false,"shares":10505,"price":22.5213,"value":236586.2565,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $21.80 to $22.80, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":4495,"source":{"system":"sec-edgar","filing":"0001415889-23-001966","document":"form4-02032023_060202.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588923001966/form4-02032023_060202.xml","form_type":"4"}},{"id":2033187,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2023-02-03T23:00:21.000Z","date":"2023-02-01","kind":"exercise","acquired":true,"shares":15000,"price":2.14,"value":32100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2022."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001415889-23-001966","document":"form4-02032023_060202.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588923001966/form4-02032023_060202.xml","form_type":"4"}},{"id":2062954,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-05T22:00:21.000Z","date":"2023-01-03","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"A total of 493,381 shares subject to an employee stock option were granted on April 2, 2021, with 25% vested on June 4, 2022, with the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":463381,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001415889-23-000551","document":"form4-01052023_050101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588923000551/form4-01052023_050101.xml","form_type":"4"}},{"id":2062953,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2023-01-05T22:00:21.000Z","date":"2023-01-03","kind":"sale","acquired":false,"shares":15,"price":29.82,"value":447.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2022."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-23-000551","document":"form4-01052023_050101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588923000551/form4-01052023_050101.xml","form_type":"4"}},{"id":2062952,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2023-01-05T22:00:21.000Z","date":"2023-01-03","kind":"sale","acquired":false,"shares":791,"price":28.7759,"value":22761.7369,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.56 to $29.40, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":15,"source":{"system":"sec-edgar","filing":"0001415889-23-000551","document":"form4-01052023_050101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588923000551/form4-01052023_050101.xml","form_type":"4"}},{"id":2062951,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2023-01-05T22:00:21.000Z","date":"2023-01-03","kind":"sale","acquired":false,"shares":2267,"price":27.9028,"value":63255.6476,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.32 to $28.29, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":806,"source":{"system":"sec-edgar","filing":"0001415889-23-000551","document":"form4-01052023_050101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588923000551/form4-01052023_050101.xml","form_type":"4"}},{"id":2062950,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2023-01-05T22:00:21.000Z","date":"2023-01-03","kind":"sale","acquired":false,"shares":11927,"price":26.7973,"value":319611.3971,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.26 to $27.17, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":3073,"source":{"system":"sec-edgar","filing":"0001415889-23-000551","document":"form4-01052023_050101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588923000551/form4-01052023_050101.xml","form_type":"4"}},{"id":2062949,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2023-01-05T22:00:21.000Z","date":"2023-01-03","kind":"exercise","acquired":true,"shares":15000,"price":2.14,"value":32100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2022."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001415889-23-000551","document":"form4-01052023_050101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588923000551/form4-01052023_050101.xml","form_type":"4"}},{"id":2098457,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-03T00:00:22.000Z","date":"2022-12-01","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"A total of 493,381 shares subject to an employee stock option were granted on April 2, 2021, with 25% vested on June 4, 2022, with the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":478381,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001415889-22-011983","document":"form4-12022022_071207.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588922011983/form4-12022022_071207.xml","form_type":"4"}},{"id":2098456,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2022-12-03T00:00:22.000Z","date":"2022-12-01","kind":"sale","acquired":false,"shares":15000,"price":18,"value":270000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2022."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-22-011983","document":"form4-12022022_071207.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588922011983/form4-12022022_071207.xml","form_type":"4"}},{"id":2098455,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2022-12-03T00:00:22.000Z","date":"2022-12-01","kind":"exercise","acquired":true,"shares":15000,"price":2.14,"value":32100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2022."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001415889-22-011983","document":"form4-12022022_071207.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588922011983/form4-12022022_071207.xml","form_type":"4"}},{"id":2125799,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2022-11-03T21:00:17.000Z","date":"2022-11-01","kind":"sale","acquired":false,"shares":1038,"price":19.5,"value":20241.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 18, 2022."},{"field":"shares","element":"transactionShares","label":"F2","text":"Includes 1,038 shares purchased under the Issuer's 2021 Employee Stock Purchase Plan on October 31, 2022 in a transaction that is exempt under Rule 16b-3(c) and 16b-3(d)."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-22-011067","document":"form4-11032022_051106.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588922011067/form4-11032022_051106.xml","form_type":"4"}},{"id":2470013,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-16T23:00:20.000Z","date":"2021-12-14","kind":"grant","acquired":true,"shares":204501,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in 48 substantially equal monthly installments, with the first installment vesting on January 14, 2022."}],"balance_after":204501,"derivative":{"exercise_price":10.61,"expiration_date":"2031-12-13","underlying":"Common Stock","underlying_shares":204501},"source":{"system":"sec-edgar","filing":"0001493152-21-031755","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000149315221031755/ownership.xml","form_type":"4"}},{"id":2647906,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-01T22:32:05.000Z","date":"2021-06-29","kind":"grant","acquired":true,"shares":271200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of this option shall vest and become exercisable on June 29, 2022, with the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":271200,"derivative":{"exercise_price":14,"expiration_date":"2031-06-28","underlying":"Common Stock","underlying_shares":271200},"source":{"system":"sec-edgar","filing":"0001104659-21-088379","document":"tm2121189-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000110465921088379/tm2121189-4_4seq1.xml","form_type":"4"}},{"id":2647905,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-01T22:32:05.000Z","date":"2021-04-02","kind":"grant","acquired":true,"shares":493381,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On June 22, 2021, the Issuer completed a one-for-3.1060103 reverse stock split of the Issuer's Common Stock (the \"Reverse Split\"). This amount has been adjusted to give effect to the Reverse Split."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction occurred prior to the Issuer's initial public offering, and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3."},{"field":"shares","element":"transactionShares","label":"F1","text":"On June 22, 2021, the Issuer completed a one-for-3.1060103 reverse stock split of the Issuer's Common Stock (the \"Reverse Split\"). This amount has been adjusted to give effect to the Reverse Split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of this option shall vest and become exercisable on June 4, 2022, with the remainder vesting in 36 substantially equal monthly installments thereafter."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"On June 22, 2021, the Issuer completed a one-for-3.1060103 reverse stock split of the Issuer's Common Stock (the \"Reverse Split\"). This amount has been adjusted to give effect to the Reverse Split."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On June 22, 2021, the Issuer completed a one-for-3.1060103 reverse stock split of the Issuer's Common Stock (the \"Reverse Split\"). This amount has been adjusted to give effect to the Reverse Split."}],"balance_after":493381,"derivative":{"exercise_price":2.144,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":493381},"source":{"system":"sec-edgar","filing":"0001104659-21-088379","document":"tm2121189-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000110465921088379/tm2121189-4_4seq1.xml","form_type":"4"}},{"id":2647904,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-01T22:32:05.000Z","date":"2021-04-02","kind":"grant","acquired":true,"shares":254253,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On June 22, 2021, the Issuer completed a one-for-3.1060103 reverse stock split of the Issuer's Common Stock (the \"Reverse Split\"). This amount has been adjusted to give effect to the Reverse Split."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction occurred prior to the Issuer's initial public offering, and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3."},{"field":"shares","element":"transactionShares","label":"F1","text":"On June 22, 2021, the Issuer completed a one-for-3.1060103 reverse stock split of the Issuer's Common Stock (the \"Reverse Split\"). This amount has been adjusted to give effect to the Reverse Split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of this option shall vest and become exercisable on February 15, 2022, with the remainder vesting in 36 substantially equal monthly installments thereafter."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"On June 22, 2021, the Issuer completed a one-for-3.1060103 reverse stock split of the Issuer's Common Stock (the \"Reverse Split\"). This amount has been adjusted to give effect to the Reverse Split."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On June 22, 2021, the Issuer completed a one-for-3.1060103 reverse stock split of the Issuer's Common Stock (the \"Reverse Split\"). This amount has been adjusted to give effect to the Reverse Split."}],"balance_after":254253,"derivative":{"exercise_price":2.144,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":254253},"source":{"system":"sec-edgar","filing":"0001104659-21-088379","document":"tm2121189-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000110465921088379/tm2121189-4_4seq1.xml","form_type":"4"}},{"id":3677050,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-04T08:00:34.000Z","date":"2019-01-31","kind":"grant","acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on January 31, 2019 and the shares underlying this option vest 25% on the first anniversary of the grant date and the remaining shares vest in twelve equal quarterly installments."}],"balance_after":350000,"derivative":{"exercise_price":2.7,"expiration_date":"2029-01-30","underlying":"Common Stock, $0.001 par value","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0001171843-19-000681","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185035/000117184319000681/ownership.xml","form_type":"4"}},{"id":4047136,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-02-20T08:15:45.000Z","date":"2018-02-16","kind":"disposition_to_issuer","acquired":false,"shares":2997,"price":2.11,"value":6323.67,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The selling price of $2.11 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $2.10 to $2.15. The reporting person undertakes to provide Proteon Therapeutics, Inc., any security holder of Proteon Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001171843-18-001229","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185035/000117184318001229/formfour.xml","form_type":"4"}},{"id":4051466,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-02-16T08:15:48.000Z","date":"2018-02-15","kind":"disposition_to_issuer","acquired":false,"shares":2245,"price":2.152,"value":4831.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The selling price of $2.152 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $2.10 to $2.25. The reporting person undertakes to provide Proteon Therapeutics, Inc., any security holder of Proteon Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":2997,"source":{"system":"sec-edgar","filing":"0001171843-18-001197","document":"f4_noyes021618.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1185035/000117184318001197/f4_noyes021618.xml","form_type":"4"}},{"id":4051465,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-02-16T08:15:48.000Z","date":"2018-02-14","kind":"disposition_to_issuer","acquired":false,"shares":3500,"price":2.2,"value":7700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The selling price of $2.20 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $2.20 to $2.23. The reporting person undertakes to provide Proteon Therapeutics, Inc., any security holder of Proteon Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":5242,"source":{"system":"sec-edgar","filing":"0001171843-18-001197","document":"f4_noyes021618.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185035/000117184318001197/f4_noyes021618.xml","form_type":"4"}},{"id":4068351,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-02-09T08:16:15.000Z","date":"2018-02-08","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on February 8, 2018 and the shares underlying this option vest 25% on the first anniversary of the grant date and the remaining shares vest in twelve equal quarterly installments."}],"balance_after":500000,"derivative":{"exercise_price":2.15,"expiration_date":"2028-02-07","underlying":"Common Stock, $0.001 par value","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001171843-18-001001","document":"formfour.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185035/000117184318001001/formfour.xml","form_type":"4"}},{"id":4097626,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-01-17T17:01:41.000Z","date":"2018-01-16","kind":"disposition_to_issuer","acquired":false,"shares":10000,"price":2.357,"value":23570.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The selling price of $2.357 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $2.30 to $2.425. The reporting person undertakes to provide Proteon Therapeutics, Inc., any security holder of Proteon Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":8742,"source":{"system":"sec-edgar","filing":"0001171843-18-000401","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185035/000117184318000401/formfour.xml","form_type":"4"}},{"id":4130105,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-12-15T17:01:09.000Z","date":"2017-12-14","kind":"disposition_to_issuer","acquired":false,"shares":10000,"price":1.854,"value":18540.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The selling price of $1.854 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $1.85 to $1.925. The reporting person undertakes to provide Proteon Therapeutics, Inc., any security holder of Proteon Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":18742,"source":{"system":"sec-edgar","filing":"0001171843-17-007706","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185035/000117184317007706/formfour.xml","form_type":"4"}},{"id":4160114,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-11-16T17:00:44.000Z","date":"2017-11-15","kind":"disposition_to_issuer","acquired":false,"shares":5650,"price":1.702,"value":9616.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The selling price of $1.702 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $1.65 to $1.725. The reporting person undertakes to provide Proteon Therapeutics, Inc., any security holder of Proteon Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":28742,"source":{"system":"sec-edgar","filing":"0001171843-17-007112","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1185035/000117184317007112/formfour.xml","form_type":"4"}},{"id":4160113,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-11-16T17:00:44.000Z","date":"2017-11-14","kind":"disposition_to_issuer","acquired":false,"shares":4350,"price":1.687,"value":7338.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The selling price of $1.687 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $1.65 to $1.80. The reporting person undertakes to provide Proteon Therapeutics, Inc., any security holder of Proteon Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":34392,"source":{"system":"sec-edgar","filing":"0001171843-17-007112","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185035/000117184317007112/formfour.xml","form_type":"4"}},{"id":4184632,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-10-17T16:45:20.000Z","date":"2017-10-16","kind":"disposition_to_issuer","acquired":false,"shares":10000,"price":2.312,"value":23120.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The selling price of $2.312 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $2.25 to $2.35. The reporting person undertakes to provide Proteon Therapeutics, Inc., any security holder of Proteon Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":38742,"source":{"system":"sec-edgar","filing":"0001171843-17-006105","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185035/000117184317006105/formfour.xml","form_type":"4"}},{"id":4206980,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-09-18T16:15:28.000Z","date":"2017-09-15","kind":"disposition_to_issuer","acquired":false,"shares":5146,"price":1.479,"value":7610.934,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The selling price of $1.479 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $1.475 to $1.50. The reporting person undertakes to provide Proteon Therapeutics, Inc., any security holder of Proteon Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":48742,"source":{"system":"sec-edgar","filing":"0001171843-17-005589","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1185035/000117184317005589/formfour.xml","form_type":"4"}},{"id":4206979,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-09-18T16:15:28.000Z","date":"2017-09-14","kind":"disposition_to_issuer","acquired":false,"shares":4854,"price":1.454,"value":7057.716,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The selling price of $1.454 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $1.425 to $1.475. The reporting person undertakes to provide Proteon Therapeutics, Inc., any security holder of Proteon Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":53888,"source":{"system":"sec-edgar","filing":"0001171843-17-005589","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185035/000117184317005589/formfour.xml","form_type":"4"}},{"id":4480431,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":90881,"kind":"person","name":"NOYES TIMOTHY P","position":1,"cik":"0001185035","reported_name":"NOYES TIMOTHY P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-01-26T08:01:41.000Z","date":"2017-01-24","kind":"grant","acquired":true,"shares":122838,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on January 24, 2017 and the shares underlying this option vest 25% on the first anniversary of the grant date and the remaining shares vest in twelve equal quarterly installments."}],"balance_after":122838,"derivative":{"exercise_price":2.05,"expiration_date":"2027-01-23","underlying":"Common Stock, $0.001 par value","underlying_shares":122838},"source":{"system":"sec-edgar","filing":"0001171843-17-000454","document":"f4_noyes012617.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185035/000117184317000454/f4_noyes012617.xml","form_type":"4"}}]}